Home › Funds › Lion Point Capital, LP › MCRB

Lion Point Capital, LP position in MCRB

SERES THERAPEUTICS INC · Health Care

Lion Point Capital, LP reported holding 31,570 shares of MCRB (SERES THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$249K, representing 1.19% of its reported portfolio and ranking #29 among its reported holdings. Lion Point Capital, LP has disclosed MCRB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)31.57K sh
Reported value held$249.09K
Portfolio Weight1.19%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's MCRB position evolved

Lion Point Capital, LP first disclosed a stake in MCRB in Q3 2023 at 691,803 shares (US$1.6M). Across 12 filings, Lion Point Capital, LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 31,570 shares valued at US$249K. Notable position changes include a 51% trim in Q4 2023 (shares fell 45% over the following quarter), a 95% trim in Q2 2025 (shares rose 73% over the following quarter), a 59% increase in Q3 2025 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 691.80K $1.65M New
Q4 2023 340.76K $477.06K Reduce
Q1 2024 340.76K $263.78K Hold
Q2 2024 340.76K $246.64K Hold
Q3 2024 340.76K $322.39K Hold
Q4 2024 340.76K $283.17K Hold
Q1 2025 340.76K $238.53K Hold
Q2 2025 17.04K $189.29K Reduce
Q3 2025 27.14K $522.13K Add
Q4 2025 31.57K $469.76K Add
Q1 2026 31.57K $280.03K Hold
Q2 2026 31.57K $249.09K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MCRB and 13F data

MCRB (SERES THERAPEUTICS INC) is a Health Care company. 10 other funds we track also report a position in MCRB — the largest reported positions include Flagship Pioneering, LLC (US$9.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MCRB

All MCRB fund holders →

FAQ

How long has Lion Point Capital, LP held MCRB?

Lion Point Capital, LP has disclosed MCRB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Lion Point Capital, LP's current position in MCRB?

As of Q2 2026, Lion Point Capital, LP holds 31.57K shares of MCRB (SERES THERAPEUTICS INC), valued at $249.09K, representing 1.19% of its reported portfolio and ranking #29.

Has Lion Point Capital, LP been buying or selling MCRB?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in MCRB.

Which other funds hold MCRB?

Other major institutional holders of MCRB include Flagship Pioneering, LLC, among 10 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.